Trials / Unknown
UnknownNCT03820518
Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
Comparing the Effectiveness of High or Low Dose of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year – 12 Years
- Healthy volunteers
- Not accepted
Summary
X-linked hypophosphatemia (XLH) is the most common form of heritable rickets. Current treatments include active vitamin D metabolites (e.g. calcitriol) and phosphate salts. There is no consistent weight-based dosing of calcitriol and phosphate now. The primary objective of this study is to establish the efficacy of different dose of calcitriol combined with neutral phosphate in children with XLH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcitriol |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2021-12-31
- Completion
- 2022-12-31
- First posted
- 2019-01-29
- Last updated
- 2019-01-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03820518. Inclusion in this directory is not an endorsement.